evaluated the effect of CDDP treatments in combination with EGCG on the expression of the CTR1 solutes carrier (Copper Transporter 1) in ovarian cancer models, which is important, considering that CTR1 has been associated with the regulation of intracellular CDDP levels. The gene discussed is SLC31A1; the disease is ovarian carcinoma.